Most prominently, the level of core fucosylation of N-glycan in alpha-fetoprotein (AFP) increases in hepatocellular carcinomas (HCC) and carcinoma metastatic to the liver, but not in benign liver diseases, such as acute viral hepatitis, chronic hepatitis, or liver cirrhosis2. This evidence concerns the gene AFP and hepatocellular carcinoma.